Evoke Pharma Inc (EVOK) Cash Money per Share

Evoke Pharma, Inc. (EVOK) specializes in gastrointestinal therapy, generating revenue from the sale of the Gimoti spray. The drug's unique format provides significant pricing power. This chart on GURU.Markets for cash per share shows a value of 6.69, reflecting the metric's current value. However, slow market adoption of the product and marketing expenses are constraining the overall profitability of the business.
Analytical breakdowns for Evoke Pharma, Inc.

This indicator is critical for liquidity stress testing and asset filtering during portfolio construction. The metric reflects the amount of available cash per common share, demonstrating the business's actual financial safety cushion. By analyzing cash-per-share trends, an investor assesses the efficiency of capital management. For Evoke Pharma, Inc. (EVOK), this reserve ensures the seamless operation of climate-controlled logistics during the distribution of nasal sprays. The stability of this indicator confirms the company's ability to maintain complex supply chains to pharmacy networks.